Health·2,849 stories
A magnitude 7.8 earthquake struck off Mindanao in the Philippines, causing building collapses and extensive damage in General Santos City. Tsunami warnings were issued for the Philippines and neighbor
Axiom Space and Prada have revealed the Liquid Cooling and Ventilation Garment (LCVG), a high-tech base layer that will keep Artemis IV astronauts cool, supplied with oxygen, and clear of CO2 inside t
STAT’s ADA in 30 Seconds newsletter released its third and final edition, covering the competitive landscape for obesity drugs, offering insights on eating disorders, highlighting a new development on
Boehringer Ingelheim’s obesity drug survodutide showed a 13% weight loss after 76 weeks in a Phase 3 trial, compared with 5% for placebo, and cut liver fat by up to 63% versus 25% for placebo. However
At the American Society of Clinical Oncology meeting, researchers unveiled several new cancer therapies, including a vaccine for head‑and‑neck tumours and an immunotherapy that may avoid bladder surge
Five leading diabetes researchers were physically removed from the American Diabetes Association's annual conference in New Orleans for distributing reprints of an editorial — published in the ADA's o
A phase‑3 trial of Eli Lilly’s weekly triple‑hormone drug retatrutide in 930 adults with type 2 diabetes showed that participants lost up to 15 % of body weight and cut HbA1c by nearly 2 % after 40 we
A new scientific review highlights the traditional Chinese root Polygonum multiflorum as a multi‑target candidate for treating androgenetic alopecia. The herb, used for more than a millennium, may blo
Daraxonrasib, a daily pill that blocks malfunctioning RAS proteins, nearly doubled median survival to 13 months in a 500-patient Phase III trial of advanced pancreatic cancer, outperforming standard c
STAT’s ADA in 30 Seconds newsletter delivers a day‑2 recap of the American Diabetes Association annual conference. The full article and premium analysis are exclusive to STAT+ subscribers, who can sig
Eli Lilly presented new safety data for its next‑generation obesity drug, retatrutide, at the American Diabetes Association meeting. In the TRANSCEND‑T2D‑1 trial, 7 of 403 participants on retatrutide
A study of over 110,000 women found that users of GLP‑1 medications—including Ozempic, Wegovy, Mounjaro, and Zepbound—had about a 30% lower risk of developing breast cancer. The observational findings
Pfizer’s obesity drug berobenatide, acquired from Metsera, was tested in the VESPER‑3 mid‑stage trial where patients switched from weekly to higher monthly doses. Those who remained on treatment lost
Older adults are increasingly using dietary supplements, yet many offer little benefit unless a specific deficiency exists. The article highlights that low vitamin B12, vitamin D, protein, and folate
A new JAMA Network Open review of diagnostic interviews from February 2024 to September 2025 found that test‑retest reliability varies across mental‑health conditions, with substance‑use disorders—esp
Scientists warn that free‑living amoebae, microbes found in water and soil, are an underappreciated public‑health risk capable of causing deadly infections and shielding other pathogens. The brain‑eat
The First Opinion Podcast hosts a conversation with medical researchers Braxton Mitchell and Cory Anderson about the Amish, public health, and vaccine attitudes. The hosts explain that the Amish are a
At a US cancer conference, researchers presented new oral and combination therapies that overcome tumor immune evasion and improve outcomes. The tablet GRWD5769 plus cemiplimab shrank tumours in 26 of
Recent research shows CRISPR base editing can modify healthy human embryos without the unwanted mutations that plagued earlier CRISPR‑Cas9 approaches. A Columbia study led by Dieter Egli achieved prec
The International Academy of Astronautics has published updated protocols for how SETI researchers should verify, announce, and manage potential signals from intelligent alien civilizations, replacing
Curated health stories, every morning. Free.
No spam. Unsubscribe anytime.